NCT05528302 · ACTIVE NOT RECRUITING
Technology Assisted Cognitive Behavioural Therapy Intervention for Anxiety in People Living With Cognitive Impairment
This trial is testing whether cognitive behavioural therapy, delivered remotely via a software platform, can help reduce anxiety in people who already have mild cognitive impairment or dementia. Researchers are measuring how well the tech-assisted therapy works compared to a control condition. Phase NA here means this is a practical, real-world style trial rather than a drug-approval study.
You may qualify if
- Persons aged 18 years or over
- Persons with a diagnosis of mild cognitive impairment (MCI) or dementia of any aetiology based on a previous diagnosis by a clinician or scoring above threshold (≤32; MCI ≤32 and dementia ≤27) for cognitive impairment in the Modified Telephone Interview for Cognitive Impairment (TICS-M).
- Screening positive for anxiety (scoring ≥9 on Geriatric Anxiety Inventory, GAI), and/or subjective complaints of anxiety and/ or clinician diagnosis of a current anxiety disorder and screening positive for anxiety using the Rating Anxiety in Dementia scale (scoring ≥11 on RAID)
You're excluded if
- Persons with severe dementia
- Persons unable to communicate or complete questionnaires
- Persons who have a current risk of suicide within the last month as determined by the study clinical expert team.
- Persons with major depression as the primary complaint without reported symptoms of anxiety
- Persons with comorbid psychiatric conditions
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-02-04